Yuebing Wang

Yuebing Wang

Auto-generated profile, based on publicly available information

Yuebing Wang

School of Medicine Institute of Transplant Medicine Tianjin First Central Hospital Nankai University Tianjin China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2020 in ACS Nano
Verified
Journal Article
Closed access
HCHongmei Cao
Hongmei Cao
YCYuanqiu Cheng
Yuanqiu Cheng
HGHeqi Gao
Heqi Gao
JZJie Zhuang
Jie Zhuang
WZWeiguang Zhang
Weiguang Zhang
YWYuebing Wang
Yuebing Wang

7 March 2019 in ACS Nano
Verified
Journal Article
Closed access
HCHongmei Cao
Hongmei Cao
ZYZhiwei Yue
Zhiwei Yue
HGHeqi Gao
Heqi Gao
CCChao Chen
Chao Chen
KCKaige Cui
Kaige Cui
YWYuebing Wang
Yuebing Wang

29 October 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
LQLina Qiu
Lina Qiu
YCYing Cai
Ying Cai
YGYanqin Geng
Yanqin Geng
XYXiuhua Yao
Xiuhua Yao
LWLanxing Wang
Lanxing Wang
JWJialing Wu
Jialing Wu

12 August 2022 in ACS Nano
Verified
Journal Article
Closed access
HCHongmei Cao
Hongmei Cao
HGHeqi Gao
Heqi Gao
LWLanxing Wang
Lanxing Wang
YCYuanqiu Cheng
Yuanqiu Cheng
XWXiaoli Wu
Xiaoli Wu
YWYuebing Wang
Yuebing Wang

28 September 2022 in Nano Letters
Verified
Journal Article
Closed access
HCHongmei Cao
Hongmei Cao
YGYang Gao
Yang Gao
HJHaixue Jia
Haixue Jia
LZLiping Zhang
Liping Zhang
JLJinjian Liu
Jinjian Liu
JLJianfeng Liu
Jianfeng Liu

27 December 2021 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
YCYuan-Qiu Cheng
Yuan-Qiu Cheng
YYYu-Xin Yue
Yu-Xin Yue
HCHong-Mei Cao
Hong-Mei Cao
WGWen-Chao Geng
Wen-Chao Geng
LWLan-Xing Wang
Lan-Xing Wang
YWYue-Bing Wang
Yue-Bing Wang
Background: Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneous targeted kidney hypoxia imaging and therapy has yet to be established. Herein, we fabricated a unique nano-sized hypoxia-sensitive coassembly (Pc/C5A@EVs) via molecular recognition and self-assembly, which is composed of the macrocyclic amphiphile C5A, the commercial dye sulfonated aluminum phthalocyanine (Pc) and mesenchymal stem cell-excreted extracellular vesicles (MSC-EVs). Results: In murine models of unilateral or bilateral ischemia/reperfusion injury, MSC-EVs protected the Pc/C5A complex from immune metabolism, prolonged the circulation time of the complex, and specifically led Pc/C5A to hypoxic kidneys via surface integrin receptor α4β1 and αLβ2, where Pc/C5A released the near-infrared fluorescence of Pc and achieved enhanced hypoxia-sensitive imaging. Meanwhile, the coassembly significantly recovered kidney function by attenuating cell apoptosis, inhibiting the progression of renal fibrosis and reducing tubulointerstitial inflammation. Mechanistically, the Pc/C5A coassembly induced M1-to-M2 macrophage transition by inhibiting the HIF-1α expression in hypoxic renal tubular epithelial cells (TECs) and downstream NF-κB signaling pathway to exert their regenerative effects. Conclusion: This synergetic nanoscale coassembly with great translational potential provides a novel strategy for precise kidney hypoxia diagnosis and efficient kidney injury treatment. Furthermore, our strategy of coassembling exogenous macrocyclic receptors with endogenous cell-derived membranous structures may offer a functional platform to address multiple clinical needs. Graphical